US FDA’s MIDD Program Could Expand Beyond Quarterly Requests, But Needs Resources

 
• By Derrick Gingery
clinical trials
MIDD requests could be submitted more often, but resources are an issue. (Shutterstock)

More from Clinical Trials

More from R&D